Bailey, Sarah E. R. http://orcid.org/0000-0003-0020-4778
Abel, Gary A.
Atkins, Alex
Byford, Rachel
Davies, Sarah-Jane
Mays, Joe
McDonald, Timothy J.
Miller, Jon
Neck, Catherine
Renninson, John
Thomas, Paul
Walter, Fiona M.
Warren, Sarah
Hamilton, Willie
Funding for this research was provided by:
Cancer Research UK (C8640/A23385)
Article History
Received: 9 September 2020
Revised: 20 November 2020
Accepted: 2 December 2020
First Online: 19 January 2021
Ethics approval and consent to participate
: Caldicott guardians in each participating secondary care provider approved the use of data for this evaluation. As this project was not changing routine clinical practice, but evaluating existing provision, ethical approval was not required. Data sharing agreements were drawn up between all parties, and Caldicott guardian approvals were in place to allow data sharing. The requirement for individual NHS numbers for use within this evaluation meets the criteria set out in section 6 of the General Data Protection Regulation: Guidance on Lawful Processing. The processing of data is based upon GDPR Article 6(1)(e)—‘exercise of official authority’ and article 9(2)(h) ‘management of health and care services’. The enabling legislation is the NHS Act 2006 section 13E, including the duty on NHS England to ‘secure continuous improvement in the quality of services’. The same basis supported the secondary care providers supplying data.
: As the raw data analysed in this study include patient identifiable information, we cannot share them currently. We are happy to discuss requests for data with the Caldicott guardian (J.R.).
: The authors declare no competing interests.
: This research arises from the CanTest Collaborative, which is funded by Cancer Research UK [C8640/A23385], of which W.H. and F.M.W. are Directors, G.A.A. is Co-investigator and S.B. is Senior Postdoctoral Researcher. It was also supported by the Peninsula Cancer Alliance, the Somerset, Wiltshire, Avon, and Gloucestershire (SWAG) Cancer Alliance, and NHS England.